For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Irrigation that contains tranexamic acid (TXA) | Tranexamic acid injection: The breast pockets will additionally be irrigated with 150 cc of 2.67% TXA (75 cc in each breast). The TXA solution will be allowed to be sit in the breast pocket for 15 minutes and then removed after 15 minutes. | 0 | None | 0 | 55 | 6 | 55 | View |
| No additional irrigation usual care | No additional irrigation: There will be no additional irrigation after the standard surgical procedure. | 0 | None | 1 | 52 | 6 | 52 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Hematoma Requiring Reoperation | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Surgical site infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Delayed wound healing | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Rash/Dermatitis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |